日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Blood toxicogenomics reveals potential biomarkers for management of idiosyncratic drug-induced liver injury

血液毒理基因组学揭示了用于管理特异性药物性肝损伤的潜在生物标志物

Church, Rachel J; Anchang, Benedict; Bennett, Brian D; Bushel, Pierre R; Watkins, Paul B

Cannabidiol and Abnormal Liver Chemistries in Healthy Adults: Results of a Phase I Clinical Trial

大麻二酚与健康成年人肝脏化学指标异常:一项 I 期临床试验的结果

Watkins, Paul B; Church, Rachel J; Li, Jie; Knappertz, Volker

Methodological considerations for measuring biofluid-based microRNA biomarkers

测量生物体液中microRNA生物标志物的方法学考量

Chorley, Brian N; Atabakhsh, Elnaz; Doran, Graeme; Gautier, Jean-Charles; Ellinger-Ziegelbauer, Heidrun; Jackson, David; Sharapova, Tatiana; Yuen, Peter S T; Church, Rachel J; Couttet, Philippe; Froetschl, Roland; McDuffie, James; Martinez, Victor; Pande, Parimal; Peel, Lauren; Rafferty, Conor; Simutis, Frank J; Harrill, Alison H

The Challenge of Interpreting Alanine Aminotransferase Elevations in Clinical Trials of New Drug Candidates

新药临床试验中丙氨酸氨基转移酶升高结果解读的挑战

Church, Rachel J; Watkins, Paul B

Glutamate dehydrogenase as a biomarker for mitotoxicity; insights from furosemide hepatotoxicity in the mouse

谷氨酸脱氢酶作为线粒体毒性的生物标志物;来自呋塞米小鼠肝毒性的启示

Church, Rachel J; Schomaker, Shelli J; Eaddy, J Scott; Boucher, Germaine G; Kreeger, John M; Aubrecht, Jiri; Watkins, Paul B

Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort

药物性肝损伤诊断和预后的候选生物标志物:一项国际合作研究

Church, Rachel J; Kullak-Ublick, Gerd A; Aubrecht, Jiri; Bonkovsky, Herbert L; Chalasani, Naga; Fontana, Robert J; Goepfert, Jens C; Hackman, Frances; King, Nicholas M P; Kirby, Simon; Kirby, Patrick; Marcinak, John; Ormarsdottir, Sif; Schomaker, Shelli J; Schuppe-Koistinen, Ina; Wolenski, Francis; Arber, Nadir; Merz, Michael; Sauer, John-Michael; Andrade, Raul J; van Bömmel, Florian; Poynard, Thierry; Watkins, Paul B

The transformation in biomarker detection and management of drug-induced liver injury

药物性肝损伤生物标志物检测和管理的变革

Church, Rachel J; Watkins, Paul B

Beyond miR-122: Identification of MicroRNA Alterations in Blood During a Time Course of Hepatobiliary Injury and Biliary Hyperplasia in Rats

miR-122之外:大鼠肝胆损伤和胆管增生过程中血液中microRNA变化的鉴定

Church, Rachel J; Otieno, Monicah; McDuffie, James Eric; Singh, Bhanu; Sonee, Manisha; Hall, LeRoy; Watkins, Paul B; Ellinger-Ziegelbauer, Heidrun; Harrill, Alison H

Characterization of the Cytochrome P450 epoxyeicosanoid pathway in non-alcoholic steatohepatitis.

非酒精性脂肪性肝炎中细胞色素 P450 环氧二十碳酸途径的特征分析

Wells Michael A, Vendrov Kimberly C, Edin Matthew L, Ferslew Brian C, Zha Weibin, Nguyen Bobbie K H, Church Rachel J, Lih Fred B, DeGraff Laura M, Brouwer Kim L R, Barritt A Sidney 4th, Zeldin Darryl C, Lee Craig R

A systems biology approach utilizing a mouse diversity panel identifies genetic differences influencing isoniazid-induced microvesicular steatosis

利用小鼠多样性谱系的系统生物学方法,鉴定出影响异烟肼诱导的微泡性脂肪变性的遗传差异。

Church, Rachel J; Wu, Hong; Mosedale, Merrie; Sumner, Susan J; Pathmasiri, Wimal; Kurtz, Catherine L; Pletcher, Mathew T; Eaddy, John S; Pandher, Karamjeet; Singer, Monica; Batheja, Ameesha; Watkins, Paul B; Adkins, Karissa; Harrill, Alison H